Modulation of virus‐induced delayed‐type hypersensitivity by plasmid DNA encoding the cytokine interleukin‐10
Open Access
- 14 June 1998
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 94 (2) , 129-134
- https://doi.org/10.1046/j.1365-2567.1998.00496.x
Abstract
This report evaluates the efficacy of eukaryotic expression plasmids encoding cytokines at modulating the induction and expression of cutaneous delayed‐type hypersensitivity (DTH) responses to virus infections. Mice given a single intramuscular administration of cytokine DNA were subsequently infected with either herpes simplex virus (HSV) or vaccinia virus, then tested for DTH. Responses in animals given interleukin‐10 DNA were markedly suppressed for at least 5 weeks after pretreatment. Animals also expressed diminished T‐cell proliferative responses and modest changes in the balance of T helper type 1 and 2 T‐cell reactions. Treatment of animals already sensitized to express DTH, also showed inhibited responses, these taking 6–7 days after treatment to become apparent. Our results show the potency and convenience of plasmid DNA encoding cytokines to modulate inflammatory reactions. Advantages and risks of the cytokine DNA approach are briefly discussed.Keywords
This publication has 21 references indexed in Scilit:
- Mechanisms of cytokine-mediated localized immunoprotection.The Journal of Experimental Medicine, 1996
- Generation of MHC class I‐restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non‐muscle cellsImmunology, 1996
- Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells.The Journal of Experimental Medicine, 1996
- Immunostimulatory DNA Sequences Necessary for Effective Intradermal Gene ImmunizationScience, 1996
- Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.The Journal of Experimental Medicine, 1995
- Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.The Journal of Experimental Medicine, 1994
- In Vivo Effects of Interleukin-10 on Contact Hypersensitivity and Delayed-Type Hypersensitivity ReactionsJournal of Investigative Dermatology, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Macrophage deactivation by interleukin 10.The Journal of Experimental Medicine, 1991
- Direct Gene Transfer into Mouse Muscle in VivoScience, 1990